Emeritus Professor, Medicine; David Geffen School of Medicine at UCLA
Pulmonology
Dr. Donald P. Tashkin, MD
Donald Tashkin works in the field of Pulmonology. He graduated from Perelman School of Medicine at the University of Pennsylvania. He received awards:"Certificate of Appreciation for protecting the breath of life for Los Angeles residents", "Who's Who in America", "Recipient of the 2010-11 Dickson Emeritus Professorship Award for outstanding research, scholarly work, teaching and service", "Recipient of the James R. Klinenberg, MD Award for the most outstanding arthritis research in the Southern California region", "Recipient of California Medal for the most meritorious contribution to thecause, prevention and treatment of lung disease", "Listed among America's Top Doctors", "Listed in America's Registry of Outstanding Professionals", "Recipient of the Lifetime Achievement Award", "Recipient of a MERIT (Method to Extend Research In Time) Award", "Listed by Los Angeles Magazine as among "The Best Doctors in Los Angeles"", "Listed in Who's Who in America", "Listed in "Best Doctors in America"", "Recipient of Recognition for Outstanding Performance in Conducting the Lung Health Study", "Phi Beta Kappa", "Phi Lamda Upsilon (Honorary Chemical Society)", "Recipient of Merck Index Award (Chemistry)", "Fellow" and "Phi Delta Epsilon". Donald Tashkin has written publications. He has 102 publications published with PubMed. The lastest paper is: 'Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.'
Publications
- The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.
- Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgr...
- How beneficial is vaping cannabis to respiratory health compared to smoking?
- Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis.
- Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: An updated review.
- Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.
- An epidemiologic review of marijuana and cancer: an update.
- Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
- Increasing cannabis use: What we still need to know about its effects on the lung.
- Subacute bronchial toxicity induced by an electronic cigarette: take home message.
- Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.
- Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.
- Fixed Airflow Obstruction in Asthma: A Descriptive Study of Patient Profiles and Effect on Treatment Responses.
- Chronic Productive Cough is Associated with Death in Smokers with Early COPD.
- Authors' response to Walker et al.
- Roflumilast : the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD.
- A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium.
- Perceptions and Attitudes Toward the Use of Nebulized Therapy for COPD: Patient and Caregiver Perspectives.
- Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD.
- A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
- Effects of marijuana smoking on the lung.
- Variations in FEV1 decline over time in chronic obstructive pulmonary disease and its implications.
- Future of fixed-dose longacting β2-agonist and antimuscarinic combination therapy in COPD.
- Can a Minimal Intervention Reduce Secondhand Smoke Exposure Among Children with Asthma from Low Income Minority Families? Results of a Randomized Trial.
- Comparison of the variability of the annual rates of change in FEV1 determined from serial measurements of the pre- versus post-bronchodilator FEV1 over 5 years in mil...
- Is It Asthma, COPD, or Something In Between, and Does it Matter?
- Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes.
- Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trial.
- Impact of Changes in Regular Use of Marijuana and/or Tobacco On Chronic Bronchitis.
- Correlation of Cough with Disease Activity and Treatment with Cyclosphosphamide in Scleroderma Interstitial Lung Disease: Findings from the Scleroderma Lung Study.
- Body mass index (BMI) change in adulthood and lung and upper aerodigestive tract (UADT) cancers.
- COPD Progression and Individual Rates of Change in FEV1 and the BODE Index.
- {beta}-blockers associated with reduced all-cause mortality in COPD.
- Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.
- Lung cancer chemoprevention with celecoxib in former smokers.
- Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial.
- Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.
- Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group.
- Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
- Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
- Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.
- Frequent exacerbations of chronic obstructive pulmonary disease--a distinct phenotype?
- Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
- Cardiovascular safety of tiotropium in patients with COPD.
- Imaging of the distal airways.
- Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
- Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than p...
- Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers.
- Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.
- Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.
- The role of tiotropium in the hospital management of exacerbation of chronic obstructive pulmonary disease.
- Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.
- Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.
- Time course and degree of hyperinflation with metronome-paced tachypnea in COPD patients.
- A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
- The partners--airflow obstruction, emphysema, and lung cancer.
- Differential modulation of leukotriene B4 synthesis and degradation in human bronchoalveolar lavage cells by lipopolysaccharide and tobacco smoke.
- Dietary flavonoid intake and lung cancer--a population-based case-control study.
- A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers.
- Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations.
- Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease.
- Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
- Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient?
- Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
- Small airways response to naturalistic cat allergen exposure in subjects with asthma.
- Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study.
- Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
- The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
- The role of patient-centered outcomes in defining the clinical course of chronic obstructive pulmonary disease. Introduction.
- Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use.
- Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
- Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo.
- Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
- Celecoxib decreases Ki-67 proliferative index in active smokers.
- Cannabis withdrawal among non-treatment-seeking adult cannabis users.
- Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
- Epidemiologic review of marijuana use and cancer risk.
- Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?
- Strategies for quitting among non-treatment-seeking marijuana smokers.
- Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II.
- Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
- Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.
- Exhaled nitric oxide in the assessment of asthma.
- The role of long-acting bronchodilators in the management of stable COPD.
- Methanandamide increases COX-2 expression and tumor growth in murine lung cancer.
- All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema.
- IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity.
- Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
- Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine.
- Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics.
- Respiratory and immunologic consequences of marijuana smoking.
- Chronic and acute effects of "crack" cocaine on diffusing capacity, membrane diffusion, and pulmonary capillary blood volume in the lung.
- The role of small airway inflammation in asthma.
- Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal ("crack") cocaine.
- A pilot study of all-trans-retinoic acid for the treatment of human emphysema.
- Cigarette smoking behavior and respiratory alterations during sleep in a healthy population.
- Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.
- Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta.
- Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.
- Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease.
- Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.
Schools
Perelman School of Medicine University of Pennsylvania
Albert Einstein Med Center
Philadelphia Va Hospital
UCLA Med Center
Doctors Specialties
Accepted Insurances
Awards
- Certificate of Appreciation for protecting the breath of life for Los Angeles residents
- Who's Who in America
- Recipient of the 2010-11 Dickson Emeritus Professorship Award for outstanding research, scholarly work, teaching and service
- Recipient of the James R. Klinenberg, MD Award for the most outstanding arthritis research in the Southern California region
- Recipient of California Medal for the most meritorious contribution to thecause, prevention and treatment of lung disease
- Listed among America's Top Doctors
- Listed in America's Registry of Outstanding Professionals
- Recipient of the Lifetime Achievement Award
- Recipient of a MERIT (Method to Extend Research In Time) Award
- Listed by Los Angeles Magazine as among "The Best Doctors in Los Angeles"
- Listed in Who's Who in America
- Listed in "Best Doctors in America"
- Recipient of Recognition for Outstanding Performance in Conducting the Lung Health Study
- Phi Beta Kappa
- Phi Lamda Upsilon (Honorary Chemical Society)
- Recipient of Merck Index Award (Chemistry)
- Fellow
- Phi Delta Epsilon
Education
-
UCLA Medical Center
-
Albert Einstein Healthcare Network
-
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.